SOURCE: BIOLASE Technology, Inc.

July 10, 2007 09:00 ET

BIOLASE Comments on Market Activity

IRVINE, CA--(Marketwire - July 10, 2007) - BIOLASE Technology, Inc. (NASDAQ: BLTI), the world's leading dental laser company, today stated that it is not aware of why there has been a significant stock price decline in recent trading sessions. President and CEO Jeffrey W. Jones said that the Company's operational results for the quarter just ended were on track and that management is looking forward to sharing its progress in detail when it announces those results.

BIOLASE currently plans to announce its results at 6:00 AM EDT on August 7, 2007 and to hold an investor conference call at 9:00 AM EDT that same morning. Instructions to access the call will be announced next week.

About BIOLASE Technology, Inc.

BIOLASE Technology, Inc. (http://www.biolase.com), the world's leading dental laser company, is a medical technology company that develops, manufactures and markets lasers and related products focused on technologies that advance the practice of dentistry and medicine. The Company's products incorporate patented and patent pending technologies designed to provide clinically superior performance with less pain and faster recovery times. BIOLASE's principal products are dental laser systems that perform a broad range of dental procedures, including cosmetic and complex surgical applications. Other products under development address ophthalmology and other medical and consumer markets.

This press release may contain forward-looking statements within the meaning of safe harbor provided by the Securities Reform Act of 1995 that are based on the current expectations and estimates by our management. These forward-looking statements can be identified through the use of words such as "anticipates," "expects," "intends," "plans," "believes," "seeks," "estimates," "may," "will," and variations of these words or similar expressions. Forward-looking statements are based on management's current, preliminary expectations and are subject to risks, uncertainties and other factors which may cause the Company's actual results to differ materially from the statements contained herein, and are described in the Company's reports it files with the Securities and Exchange Commission, including its annual and quarterly reports. No undue reliance should be placed on forward-looking statements. Such information is subject to change, and we undertake no obligation to update such statements.

Contact Information

  • For further information, please contact:

    Jeffrey W. Jones
    President & CEO
    Richard L. Harrison
    Executive Vice President and CFO
    BIOLASE Technology, Inc.
    +1-949-361-1200

    Jill Bertotti
    Allen & Caron
    +1-949-474-4300